← Back to patent-cliff list
CAS 55-21-0
Benzamide
Codes: (XXIV)145089-2-c
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1(S)-(3-Methoxyphenyl)-N,N-dimethylethylamine→(+/-)-3-Methoxy-alpha-methylbenzyl alcohol→(S)-(-)-2-Methyl-2-propanesulfinamide→(SS)-N-[(1S)-1-(3-Methoxyphenyl)ethyl]-2-methylpropane-2-sulfinamide→(1S)-1-(3-Methoxyphenyl)ethanamine→1-Ethyl-3-iodobenzene→Benzamide→N-[(1S)-1-(3-Iodophenyl)ethyl]benzamide→Hydroxymethane→N-[(1S)-1-(3-Methoxyphenyl)ethyl]benzamide→1,1,1-Triphenylmethanamine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.